Fresenius Kabi inaugurates the new line, 28 million investment
An investment of over 28 million euros, part of a broader three-year investment plan in Italy worth a total of 100 million euros, to increase the...
Fresenius Kabi has inaugurated a new production line at its Isola della Scala site in Verona, Italy, with an investment of over €28 million. The site is one of the main European hubs for the production of infusion solutions, and it covers around 40% of Italy's hospital needs for such solutions. The investment is part of a broader three-year plan worth €100 million, and it aims to increase the production capacity of plastic bottles for infusion therapies.
The company's strategy is to produce medicines locally, reducing dependence on supplies from third countries and increasing the resilience of supply chains. The expansion will be accompanied by technological innovation and is expected to strengthen the site's industrial development, professional valorization, and job growth in the area.
Written by urgent.news from Il Sole 24 Ore's report — not a translation of it. Machine-written — may contain errors; check the original before relying on it.
